Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

M1850000

Metronidazole

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

2-Methyl-5-nitroimidazole-1-ethanol

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C6H9N3O3
Numéro CAS:
443-48-1
Poids moléculaire :
171.15
Numéro Beilstein :
611683
Numéro MDL:
MFCD00009750
Code UNSPSC :
41116107
ID de substance PubChem :
329817897
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

metronidazole

Fabricant/nom de marque

EDQM

Pf

159-161 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

CC1=NC=C([N+]([O-])=O)N1CCO

InChI

1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3

Clé InChI

VAOCPAMSLUNLGC-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Metronidazole EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1050

Acide benzoique, Pharmaceutical Secondary Standard; Certified Reference Material

1055002

Acide benzoique, United States Pharmacopeia (USP) Reference Standard

Y0000087

Metronidazole impurity A, European Pharmacopoeia (EP) Reference Standard

M1851000

Metronidazole benzoate, European Pharmacopoeia (EP) Reference Standard

Y0001470

Acide benzoique, European Pharmacopoeia (EP) Reference Standard

1442009

Metronidazole, United States Pharmacopeia (USP) Reference Standard

1442100

Metronidazole benzoate, United States Pharmacopeia (USP) Reference Standard

BP603

Metronidazole, British Pharmacopoeia (BP) Reference Standard

BP244

2-Methyl-5-nitroimidazole, British Pharmacopoeia (BP) Reference Standard

BP735

Metronidazole benzoate, British Pharmacopoeia (BP) Reference Standard

PHR2165

Metronidazole Impurity F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2514

Metronidazole Impurity B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2512

Metronidazole Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Pictogrammes

Health hazard
GHS08

Mention d'avertissement

Danger

Mentions de danger

H340,H350,H373

Classification des risques

Carc. 1B - Muta. 1B - STOT RE 2

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Sonja Löfmark et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 50 Suppl 1, S16-S23 (2010-01-14)
Metronidazole has been used for the treatment of infections for >45 years and is still successfully used for the treatment of trichomoniasis, amoebiasis, and giardiasis. Anaerobic bacterial infections caused by Bacteroides species, fusobacteria, and clostridia respond favorably to metronidazole therapy.
Konstantinos Z Vardakas et al.
International journal of antimicrobial agents, 40(1), 1-8 (2012-03-09)
The objective of this review was to evaluate the frequency of treatment failure and recurrence of Clostridium difficile infection (CDI) following treatment with vancomycin or metronidazole in recently performed studies (last 10 years). Searches in PubMed and Scopus were performed
Fabrizio Sgolastra et al.
Journal of periodontology, 83(6), 731-743 (2011-11-05)
The systemic use of combined amoxicillin and metronidazole (AMX/MET) as an adjunctive treatment to full-mouth scaling and root planing (FMSRP) has been proposed for the treatment of generalized aggressive periodontitis; however, its effectiveness and clinical safety remain to be defined.
David B Stewart et al.
Annals of surgery, 260(2), 299-304 (2014-01-01)
To identify Clostridium difficile genotypes, which are associated with recurrent C difficile infection (RCDI). Reliable bacterial genetic factors predicting RCDI are currently lacking. Inpatients and outpatients 18 years or older treated at our institution for C difficile infection (CDI) of
Michael John Aldape et al.
The Journal of antimicrobial chemotherapy, 70(1), 153-159 (2014-08-26)
Clostridium difficile infection (CDI) is mediated by potent extracellular toxins and is spread largely via bacterial spores. We and others have shown that some antibiotics stimulate C. difficile toxin production in a strain-specific manner; however, the effects of newer anti-C.
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique